Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.

Ozaki T, Inoue K, Mishima T, Ohashi T, Osaki S, Ueda Y, Masuda M, Sunaga A, Tanaka N, Watanabe T, Minamiguchi H, Egami Y, Oka T, Minamisaka T, Kanda T, Okada M, Kawasaki M, Matsuda Y, Tanaka K, Makino N, Kida H, Hikoso S, Dohi T, Sotomi Y, Sakata Y, OCVC‐SUPPRESS‐AF investigators *

Open source

DOI
10.1161/jaha.125.047450
Published
2026 Jun 16
Container
Journal of the American Heart Association
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/jaha.125.047450,
  title = {Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.},
  author = {Ozaki T and Inoue K and Mishima T and Ohashi T and Osaki S and Ueda Y and Masuda M and Sunaga A and Tanaka N and Watanabe T and Minamiguchi H and Egami Y and Oka T and Minamisaka T and Kanda T and Okada M and Kawasaki M and Matsuda Y and Tanaka K and Makino N and Kida H and Hikoso S and Dohi T and Sotomi Y and Sakata Y and OCVC‐SUPPRESS‐AF investigators *},
  year = {2026},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.125.047450},
  url = {https://doi.org/10.1161/jaha.125.047450}
}

RIS

TY  - JOUR
TI  - Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.
AU  - Ozaki T
AU  - Inoue K
AU  - Mishima T
AU  - Ohashi T
AU  - Osaki S
AU  - Ueda Y
AU  - Masuda M
AU  - Sunaga A
AU  - Tanaka N
AU  - Watanabe T
AU  - Minamiguchi H
AU  - Egami Y
AU  - Oka T
AU  - Minamisaka T
AU  - Kanda T
AU  - Okada M
AU  - Kawasaki M
AU  - Matsuda Y
AU  - Tanaka K
AU  - Makino N
AU  - Kida H
AU  - Hikoso S
AU  - Dohi T
AU  - Sotomi Y
AU  - Sakata Y
AU  - OCVC‐SUPPRESS‐AF investigators *
PY  - 2026
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.125.047450
UR  - https://doi.org/10.1161/jaha.125.047450
ER  - 

APA

T, O., K, I., T, M., T, O., S, O., Y, U., M, M., A, S., N, T., T, W., H, M., Y, E., T, O., T, M., T, K., M, O., M, K., Y, M., K, T., N, M., H, K., S, H., T, D., Y, S., Y, S., & *, O. I. (2026). Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047450

Source records